NOVAGREEN IS APPROVED FOR COMMERCIAL USE BY THE ISRAELI MINISTRY OF HEALTH (YAKAR)
Results and Data analysis
safety and efficacy requirements prior approval for pilots and commercialization
Summary of test results
Abbreviations
- *“HTHC”– High THC strain
- *“BLNC”– Balanced THC/CBD strain
- *“HCBD”– High CBD strain
All tests has been performed in a GMP certified lab.
All tests passed successfully but one that was done on old cannabis and had a positive Pseudomonas.
Device has been approved for SAFTY and EFFICACY.
Data in this presentation was submitted to the YAKAR.
No observation of visual changes in the treated cannabis.
Appearance
Cannabinoids Analysis Post Treatment
No significant change in cannabinoids concentration post treatments.
* Allowed cannabinoids concentration in next slide
Allowed Cannabinoids Concentration
Foreign Materials Analysis
No foreign materials introduced in the treatment process.
Microbiology
Samples: three samples from three different batches from two different strains (high THC low CBD and high CBD low THC).
Success criteria: meets the criteria at the IMC-GMP 152, 7.7.
Toxins analysis
